NUCALA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 72079ae0c56404f4
Drug Cima Aemps Name: NUCALA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number: 1151043009
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2022-10-18
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 40 MG
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

MEPOLIZUMAB

40 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 18, 2022

Approval ID

72079ae0c56404f4

Type

Standard